Marco Maria D’Andrea

MgrB Inactivation Is a Common Mechanism of Colistin Resistance in KPC-Producing Klebsiella pneumoniae of Clinical Origin

Antonio Cannatelli, Tommaso Giani, Marco Maria D’Andrea et al. · Antimicrobial Agents and Chemotherapy · 2014 · 378 citations · Full text

Mgrb Inactivation, Klebsiella Pneumoniae, Bacteriology +18

<i>In Vivo</i> Emergence of Colistin Resistance in Klebsiella pneumoniae Producing KPC-Type Carbapenemases Mediated by Insertional Inactivation of the PhoQ/PhoP <i>mgrB</i> Regulator

Antonio Cannatelli, Marco Maria D’Andrea, Tommaso Giani et al. · Antimicrobial Agents and Chemotherapy · 2013 · 347 citations · Full text

Characterization of poxtA, a novel phenicol–oxazolidinone–tetracycline resistance gene from an MRSA of clinical origin

Alberto Antonelli, Marco Maria D’Andrea, Andrea Brenciani et al. · Journal of Antimicrobial Chemotherapy · 2018 · 254 citations · Full text

Multiple CTX-M-Type Extended-Spectrum β-Lactamases in Nosocomial Isolates of <i>Enterobacteriaceae</i> from a Hospital in Northern Italy

Laura Pagani, Emanuela Dell’Amico, Roberta Migliavacca et al. · Journal of Clinical Microbiology · 2003 · 244 citations · Full text

Antimicrobial Susceptibility, Health Sciences, Antibiotics +15

<i>In Vivo</i> Evolution to Colistin Resistance by PmrB Sensor Kinase Mutation in KPC-Producing Klebsiella pneumoniae Is Associated with Low-Dosage Colistin Treatment

Antonio Cannatelli, Vincenzo Di Pilato, Tommaso Giani et al. · Antimicrobial Agents and Chemotherapy · 2014 · 141 citations · Full text